Guardant Health Inc.(GH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GH Guardant Health Inc.

Not Yet Opened 12-17 16:00:00 EST

97.47

-2.53

-2.53%

盘后96.14

-1.33-1.37%

19:59 EST

High101.46	Low96.95	Vol1.91M
Open101.46	D1 Closing100.00	Amplitude4.51%
Mkt Cap12.61B	Tradable Cap12.09B	Total Shares129.37M
T/O187.49M	T/O Rate1.54%	Tradable Shares124.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GH","market":"US","secType":"STK","nameCN":"Guardant Health Inc.","latestPrice":97.47,"timestamp":1766005200000,"preClose":100,"halted":0,"volume":1912703,"hourTrading":{"tag":"盘后","latestPrice":96.1381,"preClose":97.47,"latestTime":"19:59 EST","volume":131366,"amount":12803047.83,"timestamp":1766019599463},"delay":0,"floatShares":124000000,"shares":129374422,"eps":-3.212374,"marketStatus":"Not Yet Opened","change":-2.53,"latestTime":"12-17 16:00:00 EST","open":101.46,"high":101.46,"low":96.95,"amount":187487088.22818,"amplitude":0.0451,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.212374,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766048400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1538625600000,"exchange":"NASDAQ","adjPreClose":100,"preHourTrading":{"tag":"盘前","latestPrice":101.27,"preClose":100,"latestTime":"09:29 EST","volume":126,"amount":12727.00926,"timestamp":1765981799999},"postHourTrading":{"tag":"盘后","latestPrice":96.1381,"preClose":97.47,"latestTime":"19:59 EST","volume":131366,"amount":12803047.83,"timestamp":1766019599463},"volumeRatio":0.951846,"impliedVol":0.655,"impliedVolPercentile":0.648},"requestUrl":"/m/hq/s/GH/tweets","defaultTab":"tweets","newsList":[{"id":"2592944957","title":"Guardant Health CTO Darya Chudova Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592944957","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/2592944957?lang=en_us&edition=fundamental","pubTime":"2025-12-18 08:18","pubTimestamp":1766017096,"startTime":"0","endTime":"0","summary":"Darya Chudova, Chief Technology Officer of Guardant Health Inc., reported a disposal of common shares of Guardant Health Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL7gmdww:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health CTO Darya Chudova Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","GH","BK4196","BK4535","BK4588","BK4585"],"gpt_icon":0},{"id":"2592993944","title":"Helmy Eltoukhy, Co-Chief Executive Officer, Reports Disposal of Guardant Health Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592993944","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592993944?lang=en_us&edition=fundamental","pubTime":"2025-12-18 08:19","pubTimestamp":1766017158,"startTime":"0","endTime":"0","summary":"Helmy Eltoukhy, Co-Chief Executive Officer and Director of Guardant Health Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDLb89h9H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4551","GH","BK4535","BK4196","BK4588"],"gpt_icon":0},{"id":"2592994451","title":"Rpt-Lantheus Holdings Inc : Mizuho Raises Target Price to $72 From $60","url":"https://stock-news.laohu8.com/highlight/detail?id=2592994451","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592994451?lang=en_us&edition=fundamental","pubTime":"2025-12-17 19:50","pubTimestamp":1765972237,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nL8N3XN0X0:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0205193047.USD","BK4196","IE0034390439.USD","MDXG","INSP","BK4585","HAE","LNTH","BK4535","IE00BLDYK493.USD","LU1169589451.USD","LU0012050646.USD","LU0205194284.USD","LU1169590202.USD","BK4167","LU0106261612.USD","IE00B64QTZ34.USD","BK4139","GH","BK4588","BK4551","IE00B19Z6F94.USD","BK4082","LU2065731478.USD","BK4198"],"gpt_icon":0},{"id":"2592456994","title":"Rpt-Inspire Medical Systems Inc : Mizuho Raises Target Price to $130 From $110","url":"https://stock-news.laohu8.com/highlight/detail?id=2592456994","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592456994?lang=en_us&edition=fundamental","pubTime":"2025-12-17 19:50","pubTimestamp":1765972236,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nL8N3XN0X0:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GH","LU0106261612.USD","LU0012050646.USD","LU0205194284.USD","BK4082","BK4139","BK4196","LNTH","IE00B19Z6F94.USD","LU0205193047.USD","IE0034390439.USD","BK4167","LU2065731478.USD","LU1169590202.USD","MDXG","BK4588","IE00BLDYK493.USD","BK4535","IE00B64QTZ34.USD","BK4551","BK4198","HAE","LU1169589451.USD","INSP","BK4585"],"gpt_icon":0},{"id":"2592994454","title":"Rpt-Haemonetics Corp : Mizuho Raises Target Price to $90 From $75","url":"https://stock-news.laohu8.com/highlight/detail?id=2592994454","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592994454?lang=en_us&edition=fundamental","pubTime":"2025-12-17 19:50","pubTimestamp":1765972235,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nL8N3XN0X0:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","BK4082","BK4588","HAE","IE00BLDYK493.USD","IE00B19Z6F94.USD","LNTH","LU2065731478.USD","BK4167","GH","INSP","BK4585","MDXG","IE00B64QTZ34.USD","LU0205193047.USD","BK4551","LU0205194284.USD","BK4139","LU1169590202.USD","IE0034390439.USD","LU1169589451.USD","LU0012050646.USD","BK4196","LU0106261612.USD","BK4535"],"gpt_icon":0},{"id":"2591141621","title":"Guardant Health Is Maintained at Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2591141621","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591141621?lang=en_us&edition=fundamental","pubTime":"2025-12-16 04:57","pubTimestamp":1765832220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 15, 2025 15:57 ET (20:57 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4535","BK4585","BK4196","GH","BK4588"],"gpt_icon":0},{"id":"2591562506","title":"Guardant Health (GH) Valuation Check After New Trial Library Alliance in Precision Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2591562506","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591562506?lang=en_us&edition=fundamental","pubTime":"2025-12-16 00:11","pubTimestamp":1765815075,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) just deepened its footprint in oncology research with a new alliance, pairing its liquid biopsy data with Trial Library’s AI platform to make cancer trial access smoother and more equitable across the United States.\nSee our latest analysis for Guardant Health.\nThose kinds of partnerships have landed at a moment when sentiment has already turned sharply, with Guardant’s 90 day share price return of 84.24 percent and year to date share price gain of 221.28 percent signaling...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-valuation-check-after-new-trial-library-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-valuation-check-after-new-trial-library-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4535","BK4585","GH","BK4588","DCF","BK4551","BK4196"],"gpt_icon":0},{"id":"2591455266","title":"Guardant Health Inc : Leerink Partners Raises Target Price to $155 From $115","url":"https://stock-news.laohu8.com/highlight/detail?id=2591455266","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591455266?lang=en_us&edition=fundamental","pubTime":"2025-12-15 20:00","pubTimestamp":1765800047,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nFWN3XL0JX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4551","GH","BK4588","BK4196","BK4535"],"gpt_icon":0},{"id":"2591643831","title":"Guardant Health, Inc. : Wells Fargo Raises Target Price to $120 From $93","url":"https://stock-news.laohu8.com/highlight/detail?id=2591643831","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591643831?lang=en_us&edition=fundamental","pubTime":"2025-12-15 19:22","pubTimestamp":1765797727,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nAZN4RF9SC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4551","BK4535","BK4585","BK4196","GH","BK4588"],"gpt_icon":0},{"id":"2590413355","title":"Guardant Health Is Maintained at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2590413355","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590413355?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:19","pubTimestamp":1765487940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 11, 2025 16:19 ET (21:19 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH","BK4588","BK4535","BK4196","BK4585","BK4551"],"gpt_icon":0},{"id":"2590165395","title":"Guardant Health Partners with Trial Library to Expand Access to Cancer Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2590165395","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590165395?lang=en_us&edition=fundamental","pubTime":"2025-12-11 21:05","pubTimestamp":1765458330,"startTime":"0","endTime":"0","summary":"Guardant Health Inc., a leading precision oncology company, has announced a strategic collaboration with Trial Library, an AI technology company focused on expanding access to oncology clinical trials. The partnership aims to increase equitable access to cancer clinical trials across the United States by integrating Guardant Health's genomic data with Trial Library's AI-powered patient matching and navigation platform. This initiative seeks to streamline the identification, referral, and enrollment of diverse and underserved patient populations into precision oncology clinical trials, helping providers offer new treatment opportunities and improving participation rates in cancer research.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDLC5Ydv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4535","GH","BK4585","BK4588","BK4196"],"gpt_icon":0},{"id":"2590165935","title":"Guardant Health Announces Collaboration With Trial Library to Increase Access to Cancer Clinical Trials Across the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2590165935","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590165935?lang=en_us&edition=fundamental","pubTime":"2025-12-11 21:05","pubTimestamp":1765458300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nTUA3WBCJD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","GH","BK4535","BK4551","BK4585","BK4588"],"gpt_icon":0},{"id":"2590590987","title":"We Think GH Research (NASDAQ:GHRS) Can Easily Afford To Drive Business Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2590590987","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590590987?lang=en_us&edition=fundamental","pubTime":"2025-12-11 18:25","pubTimestamp":1765448733,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ghrs/gh-research/news/we-think-gh-research-nasdaqghrs-can-easily-afford-to-drive-b","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ghrs/gh-research/news/we-think-gh-research-nasdaqghrs-can-easily-afford-to-drive-b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4588","SQQQ","BK4196","BK4535","NQmain","PSQ","NVIW.SI","MNQmain","BK4551","GHRS",".IXIC","USAW.SI","USJW.SI","BK4007","GH","QLD","TQQQ","BK4539","QID","TSYW.SI"],"gpt_icon":1},{"id":"2590568750","title":"Guardant Health CIO Kumud Kalia Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590568750","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590568750?lang=en_us&edition=fundamental","pubTime":"2025-12-11 10:33","pubTimestamp":1765420397,"startTime":"0","endTime":"0","summary":"Kumud Kalia, Chief Information Officer of Guardant Health Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 10, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL4bGmcp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4588","BK4551","GH","BK4585","BK4196"],"gpt_icon":0},{"id":"2590156875","title":"Director Manuel Hidalgo Medina Reports Disposal of Guardant Health Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590156875","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590156875?lang=en_us&edition=fundamental","pubTime":"2025-12-11 10:32","pubTimestamp":1765420366,"startTime":"0","endTime":"0","summary":"Manuel Hidalgo Medina, Director at Guardant Health Inc., reported a disposal of common shares of Guardant Health Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"b038ff687efe36210ac6c40aceddb1eb","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL1vN4ZB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Director Manuel Hidalgo Medina Reports Disposal of Guardant Health Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","GH","BK4196","BK4588","BK4551","BK4535"],"gpt_icon":0},{"id":"2590349567","title":"Guardant Health Launches In-House Liquid Biopsy Testing Service at Policlinico Gemelli in Italy","url":"https://stock-news.laohu8.com/highlight/detail?id=2590349567","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590349567?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:05","pubTimestamp":1765285515,"startTime":"0","endTime":"0","summary":"Guardant Health Inc., a leading precision oncology company, has launched FPG 360, an in-house liquid biopsy testing service at the Fondazione Policlinico Universitario Agostino Gemelli IRCCS in Rome, Italy. This expansion marks one of the first dedicated liquid biopsy testing facilities within a hospital system in Italy and is intended to provide local cancer patients with access to comprehensive genomic profiling without the need to send samples abroad. The partnership supports both routine care and clinical research, and builds on Guardant Health's previous collaborations with top-tier European hospitals, further expanding access to precision oncology diagnostics across the region.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guard","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL1vkGdy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4585","BK4588","GH","BK4535","BK4551"],"gpt_icon":0},{"id":"2590395538","title":"Guardant Health Chief Commercial Officer Chris Freeman Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590395538","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590395538?lang=en_us&edition=fundamental","pubTime":"2025-12-09 10:38","pubTimestamp":1765247895,"startTime":"0","endTime":"0","summary":"Chris Freeman, Chief Commercial Officer of Guardant Health Inc., reported a disposal of common shares of Guardant Health Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 08, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL5yRmF9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Chief Commercial Officer Chris Freeman Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4535","GH","BK4551","BK4588","BK4585"],"gpt_icon":0},{"id":"2589919897","title":"Guardant Health Unveils Data on Liquid Biopsy Tests for Breast Cancer at SABCS 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2589919897","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589919897?lang=en_us&edition=fundamental","pubTime":"2025-12-05 21:05","pubTimestamp":1764939921,"startTime":"0","endTime":"0","summary":"Guardant Health Inc. announced that it will present 14 abstracts at the 2025 San Antonio Breast Cancer Symposium, taking place December 9-12, 2025. The presentations will include results from studies utilizing Guardant Reveal, the company's tissue-free test for detecting minimal residual disease , and Guardant360 Liquid, a comprehensive multiomic profiling test. Highlights include data demonstrating the clinical utility of Guardant Reveal in predicting outcomes for patients with early-stage HER2-positive breast cancer, with early circulating tumor DNA  clearance during treatment associated with improved outcomes. The company's findings underscore the potential of blood-based, non-invasive testing to inform treatment selection and patient management across early and metastatic breast cancer settings. Results from these studies will be presented at the upcoming symposium.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL7RxRJS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4196","BK4551","BK4535","GH","BK4588"],"gpt_icon":0},{"id":"2588050075","title":"Guardant Health Is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2588050075","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588050075?lang=en_us&edition=fundamental","pubTime":"2025-12-03 01:50","pubTimestamp":1764697800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 02, 2025 12:50 ET (17:50 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4585","GH","BK4196","BK4588","BK4551"],"gpt_icon":0},{"id":"2588803778","title":"Morgan Stanley Raises Price Target on Guardant Health to $130 From $105, Keeps Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2588803778","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588803778?lang=en_us&edition=fundamental","pubTime":"2025-12-02 19:48","pubTimestamp":1764676128,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) has an average rating of buy and mean price target of $101.73, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4196","GH","BK4585","BK4588","BK4551","BK4535"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.guardanthealth.com","stockEarnings":[{"period":"1week","weight":-0.0502},{"period":"1month","weight":0.0103},{"period":"3month","weight":0.6577},{"period":"6month","weight":0.9835},{"period":"1year","weight":1.7976},{"period":"ytd","weight":2.1905}],"compareEarnings":[{"period":"1week","weight":-0.0235},{"period":"1month","weight":0.0086},{"period":"3month","weight":0.0138},{"period":"6month","weight":0.1298},{"period":"1year","weight":0.1111},{"period":"ytd","weight":0.1456}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.064605},{"month":2,"riseRate":0.285714,"avgChangeRate":0.06426},{"month":3,"riseRate":0.571429,"avgChangeRate":-0.023739},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.017651},{"month":5,"riseRate":0.571429,"avgChangeRate":0.065461},{"month":6,"riseRate":0.714286,"avgChangeRate":0.081894},{"month":7,"riseRate":0.714286,"avgChangeRate":0.051469},{"month":8,"riseRate":0.571429,"avgChangeRate":0.08346},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.065825},{"month":10,"riseRate":0.285714,"avgChangeRate":0.030366},{"month":11,"riseRate":0.75,"avgChangeRate":0.130427},{"month":12,"riseRate":0.5,"avgChangeRate":-0.071882}],"exchange":"NASDAQ","name":"Guardant Health Inc.","nameEN":"Guardant Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Guardant Health Inc.(GH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Guardant Health Inc.(GH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Guardant Health Inc.,GH,Guardant Health Inc.股票,Guardant Health Inc.股票老虎,Guardant Health Inc.股票老虎国际,Guardant Health Inc.行情,Guardant Health Inc.股票行情,Guardant Health Inc.股价,Guardant Health Inc.股市,Guardant Health Inc.股票价格,Guardant Health Inc.股票交易,Guardant Health Inc.股票购买,Guardant Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Guardant Health Inc.(GH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Guardant Health Inc.(GH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction